The SNF1 gene product, a serine/threonine protein kinase, is a global regulatory protein which has been isolated from several organisms. In Saccharomyces cerevisiae the SNF1 gene product is essential for the derepression of glucose repression since snf1 strains are unable to utilize sucrose, galactose, maltose, melibiose, or nonfermentable carbohydrates. Moreover, the SNF1 gene product was suggested to interact with additional regulatory pathways and to affect the expression of multiple target genes as reflected by the pleiotropic nature of the snf1 mutation. Here we report the characterization of the SNF1 homolog of Candida glabrata, a pathogenic yeast phylogenetically related to S. cerevisiae. The carbon utilization spectrum of C. glabrata is considerably narrower than that of other pathogenic yeasts, and the majority of the strains utilize solely glucose and trehalose from among 20 of the most commonly tested carbohydrates. Disruption of the C. glabrata SNF1 homolog resulted in the loss of the ability to utilize trehalose, indicating that even in an organism with such a limited carbon utilization spectrum, the regulatory mechanism governing catabolic repression is preserved.
The SNF1 gene product, a serine/threonine protein kinase, is a global regulatory protein which has been isolated from several organisms. In Saccharomyces cerevisiae the SNF1 gene product is essential for the derepression of glucose repression since snf1 strains are unable to utilize sucrose, galactose, maltose, melibiose, or nonfermentable carbohydrates. Moreover, the SNF1 gene product was suggested to interact with additional regulatory pathways and to affect the expression of multiple target genes as reflected by the pleiotropic nature of the snf1 mutation. Here we report the characterization of the SNF1 homolog of Candida glabrata, a pathogenic yeast phylogenetically related to S. cerevisiae. The carbon utilization spectrum of C. glabrata is considerably narrower than that of other pathogenic yeasts, and the majority of the strains utilize solely glucose and trehalose from among 20 of the most commonly tested carbohydrates. Disruption of the C. glabrata SNF1 homolog resulted in the loss of the ability to utilize trehalose, indicating that even in an organism with such a limited carbon utilization spectrum, the regulatory mechanism governing catabolic repression is preserved.
Candida glabrata (Torulopsis glabrata) is a haploid, asexual pathogenic yeast increasingly recovered from clinical specimens (18) . The yeast can cause superficial mucosal infection as well as fungemia in immunocompromised or severely ill immunocompetent patients (18, 32) . Frequently, C. glabrata coinfects with the more virulent yeast Candida albicans from which it can be readily discriminated by its inability to produce germ tubes in serum and its distinct pattern of carbon source utilization (18) . Recently, with the increasing number of infections caused by drug-resistant isolates and the emergence of fungal nosocomial infections (14, 24) , considerable attention has been directed to the study of C. glabrata and other less prominent opportunistic yeasts. In addition to its importance as a pathogen, C. glabrata may also be a model for the study of other closely related pathogenic yeasts, such as C. albicans and Candida tropicalis. The advantages presented by C. glabrata include haploidy and its ability to express Saccharomyces cerevisiae genes (20) .
Although the knowledge regarding the molecular biology of C. glabrata is rather limited, notable progress has been made in recent years. Winge and coworkers developed a transformation system by cloning an ARS-like sequence and the S. cerevisiae LEU2 gene into an episomal shuttle vector which was further improved to confer stability (19, 20) . Another transformation system using a C. glabrata ura3 mutant has also been described (34) . Several structural sequences including the MT-II gene cluster (20) , ERG11 (8), ERG3 (8), HIS3, TRP1 (16) , and the DNA binding domain of the AMT1 transcription factor (19) have been characterized and provide the basis for further molecular studies.
The SNF1 (sucrose nonfermenting) gene was first identified by a screening of S. cerevisiae for mutants unable to grow on sucrose as the sole carbon source (5) . Additional snf1 mutants were independently isolated based on their inability to utilize ethanol (ccr1) or glycerol and maltose (cat1) (6) . Genetic and molecular analysis of these mutants led to the recognition of the SNF1 gene as an indispensable component of the catabolic repression pathway. The SNF1 gene encodes a serine/threonine protein kinase (72 kDa) which is essential for the removal of catabolic repression (5) . It was shown that the Snf1p acts antagonistically to protein phosphatase type I by interacting with the Mig1p repressing complex, thereby relieving the transcriptional inhibition of the targeted genes (28) . The snf1 mutation exerts pleiotropic effects on multiple cellular processes such as glycogen accumulation (12) , hypersensitivity to heat shock and starvation (27) , peroxisome proliferation (25) , and sporulation (15) . Homologous sequences obtained from humans (1), rats (4), plants (2, 10, 11, 21) , and protozoan parasites (22) are suggested to play a crucial role in various stress response mechanisms and in the regulation of metabolic pathways such as the biosynthesis of cholesterol and other isoprenoid compounds (4) . Recently it was suggested that in S. cerevisiae the Snf1p interacts directly or indirectly with another distinct signal transduction pathway, RAS-cAMP, in addition to its primary role in the catabolic repression mechanism (29) .
Unlike S. cerevisiae or C. albicans, C. glabrata does not ferment or assimilate glucose-repressible sugars such as sucrose, maltose, or galactose. Trehalose, a glucose dimer, is the only sugar other than glucose that is assimilated by a majority of the C. glabrata strains (17) . Is the SNF1 gene, which controls the complex mechanism of glucose repression, being maintained in C. glabrata? Do the major components of this regulatory pathway have additional roles in this organism?
In this study, we describe the isolation and characterization of the CgSNF1 gene and demonstrate that its disruption results in the loss of trehalose utilization in C. glabrata.
MATERIALS AND METHODS

Strains.
The sources and genotypes of the strains used in this study are listed in Table 1 . C. glabrata L5SD contains an insertion of the linearized pGDV1 plasmid (see below) into the genomic SNF1 sequence, resulting in the disruption of the SNF1 gene while complementing the leucine auxotrophy of L5.
Media and growth conditions. C. glabrata and S. cerevisiae strains were maintained on YEPD agar (1% yeast extract, 2% peptone, 2% glucose) slants. DNA transformation. S. cerevisiae was transformed by the modified LiAc method (9, 13). C. glabrata was transformed by electroporation as described by Varma et al. for Cryptococcus neoformans (31) . Electrocompetent E. coli cells were transformed by electroporation following the instructions of the manufacturer (Bio-Rad Laboratories, Richmond, Calif.).
Cloning of the CgSNF1 genomic sequence. On the basis of the results of Southern blot analysis of genomic DNA with the 300-bp PCR-generated probe, EcoRI-SalI fragments (2.5 to 4.5 kb) were cloned into the Bluescript SK ϩ vector. The size-selected genomic library was introduced into E. coli DH10B cells by electroporation, and the clones were screened with the same PCR-generated probe.
Construction of a complementation vector. The 3.3-kb genomic fragment encoding the CgSNF1 sequence and flanking regions was cloned into the SalIBamHI sites of the plasmid YEp24 (NEB, Beverly, Mass.). The resulting plasmid, pGLY1, was used to transform the S. cerevisiae snf1 deletion mutant MCY2916 (Table 1) . Transformants were selected for sucrose utilization and/or uracil prototrophy. Genomic DNA was obtained from the complemented S. cerevisiae mutants by a previously described method (7) and used to transform electrocompetent E. coli cells. Plasmids were rescued from these transformants and subjected to further characterization.
Construction of a SNF1 disruption vector. A 1-kb EcoRV fragment of the
CgSNF1 coding region (Fig. 1) was cloned into the pBluescript SK ϩ vector. A 2.78-kb NaeI-AatII DNA fragment containing the S. cerevisiae LEU2 gene was obtained from the pRS405 vector (Stratagene) and was treated with T4 DNA polymerase to generate blunt ends. The LEU2 gene was inserted into the HpaI site of the cloned CgSNF1 fragment (Fig. 1) . The resulting disruption vector, pGDV1, was digested with SalI-PstI to release the CgSNF1-LEU2 chimeric sequence, which was used for the transformations of the leu2 mutant of C. glabrata, L5 (Table 1) .
Susceptibility to antifungal agents. The E-test kit (AB Biodisk, Solna, Sweden) was used to compare the in vitro susceptibilities of the wild type, leu2 mutant, and the snf1-disrupted mutants to amphotericin B and fluconazole, according to the instructions of the manufacturer.
Utilization pattern of carbon sources. The diagnostic kit api20C (BioMerieux Vitek Inc., Hazelwood, Mo.) was used to determine the carbon utilization spectrum of the reference strain and mutants. Cells were grown at 30ЊC up to 96 h and were monitored at 24-h intervals.
Nucleotide sequence analysis and accession numbers. DNA sequencing was performed by the dideoxy-mediated chain-termination method with the Sequenase version 2.0 sequencing kit as instructed by the manufacturer (U.
RESULTS
Isolation of the C. glabrata SNF1 gene. Two degenerative oligonucleotide primers were derived from conserved regions of the SNF1 gene sequence of S. cerevisiae and its plant and mammalian homologs (Fig. 2) (4, 11, 21 ). Amplification by PCR, with C. glabrata genomic DNA as template, yielded a single 300-bp DNA fragment. The PCR product hybridized strongly with the ScSNF1 probe, and analysis of its nucleotide sequence revealed a high degree of similarity with the ScSNF1 gene. Southern analysis of genomic DNA digested with various restriction enzymes indicated the existence of a single SNF1 gene (data not shown). A size-selected genomic library of C. glabrata (2.5 to 4.5 kb) was constructed in the pBluescript SK ϩ vector, and a total of 750 clones were screened. Two independent clones, each carrying an identical 3.3-kb insert containing the CgSNF1 gene and its flanking regions, were isolated and subjected to further studies.
Characterization of the CgSNF1 gene. A partial restriction map of the EcoRI-SalI 3.3-kb DNA fragment encoding the CgSNF1 gene is shown in Fig. 1 . Nucleotide sequence analysis of the CgSNF1 gene revealed an open reading frame of 1,839 bp encoding a putative 613-amino-acid polypeptide with no introns. Comparisons of the deduced amino acid sequences revealed an overall 91% similarity and 84% identity with the putative ScSnf1p sequence while only a 77% similarity and 65% identity were observed with the putative CaSnf1p sequence (Fig. 2) . Similar to ScSNF1 and CaSNF1 (23), a stretch of histidine residues was found at the amino terminus of the putative protein (Fig. 2) .
Complementation of the SNF1 deletion mutation in S. cerevisiae with the CgSNF1 gene. A SalI-BamHI 3.3-kb fragment consisting of the CgSNF1 coding regions and flanking sequences was cloned into the YEp24 vector to yield the plasmid pGLY1. This vector was used to transform an S. cerevisiae snf1⌬ mutant (MCY2916, Table 1 ) which cannot assimilate sucrose in order to test its ability to complement this phenotype. Transformants were selected for their uracil prototrophy on YNBG agar and then tested for sucrose utilization on YNBS agar plates. The randomly chosen 196 transformants tested were all able to utilize sucrose as a sole carbon source, demonstrating that both the ura3 and the snf1 mutations were complemented by pGLY1 (Fig. 3) . Crude total DNA extracts, obtained from 10 independent transformants, were used to transform electrocompetent E. coli cells. The plasmid DNA (Fig. 1) , was designed to disrupt the CgSNF1 sequence with the S. cerevisiae LEU2 gene via homologous recombination. A C. glabrata leu2 mutant, L5 (Table 1) , was transformed with the linearized pGDV1 vector by electroporation, and the resulting transformants were selected on YNBG agar for leucine prototrophy. Southern blot analysis of SalI-digested transformant DNAs with a radiolabeled CgSNF1 probe demonstrated the predicted structural modification of the SNF1 locus due to gene replacement (Fig. 4) . The shift observed in the molecular sizes of the bands hybridizing with the CgSNF1 probe (4.7 kb for the reference strain and 7.5 kb for the mutant) in about 50% of the tested clones indicated that an insertion had occurred at the targeted SNF1 sequence thereby disrupting its coding region. The rest of the clones exhibited insertions into ectopic sites in the genome (data not shown). Six of the snf1 mutants obtained were subjected to further characterization.
Analysis of the snf1 disruption mutants. The snf1 disruption mutants were tested to detect possible phenotypic modifications. The S. cerevisiae SNF1 gene and its mammalian homolog are known to play a central role in the regulation of fatty acid and cholesterol metabolism. Alteration of membrane structure and permeability therefore may result from a snf1 mutation (25, 33) . Since most commonly used antifungal agents either target the enzymes in the sterol biosynthetic pathway or bind to membrane sterol, we were interested in the susceptibility of snf1 mutants to an azole or polyene antifungal agent. None of the mutants tested with the E-test kit exhibited any change in its susceptibility to either fluconazole or amphotericin B com- Growth rates of the snf1 disruption mutant L5SD, the leu2 mutant L5, and the wild-type culture NCSSL84 were determined in YEPD media at 30 and 37ЊC. The generation time of L5 and L5SD was about 40% longer (88 min at 30ЊC) than that of the wild-type reference strain (63 min at 30ЊC). Since the L5-complemented mutant, LEU2, did not regain the wild-type generation time (8) , the slower growth rate of L5SD is probably not related to the snf1 phenotype but rather to an as yet unidentified mutation(s) acquired during the chemical mutagenesis of the leu2 mutant (20) .
The carbon utilization profile of the snf1 disruption mutants was determined with the api20C kit, which includes 20 different carbon sources. The assay indicated that both the wild type and the leu2 mutant, L5, utilize glucose and trehalose while the snf1 mutation hampered the utilization of trehalose. Further analysis on YNBT agar confirmed that snf1 mutants grow only on glucose media (YNBG, YEPD) at 30 and 37ЊC (Fig. 3) .
DISCUSSION
This report describes the isolation and characterization of the SNF1 gene homolog from the pathogenic yeast C. glabrata. An open reading frame encoding a putative 613-amino-acid protein with high similarity to those obtained from C. albicans (23) and S. cerevisiae was detected (5). Although C. glabrata is classified in the genus Candida, a higher degree of homology was observed with the SNF1 gene of S. cerevisiae than with the SNF1 homolog of C. albicans. This observation supports the relationship of the three yeasts depicted in the phylogenetic tree constructed on the basis of the small subunit rRNA sequence (3). These results also emphasize the heterogeneity among members of the genus Candida.
The similarity of CgSNF1 with ScSNF1 was demonstrated at the functional level since CgSNF1 complemented a snf1 mutant of S. cerevisiae. This result suggests that the CgSNF1 product plays similar regulatory roles in C. glabrata and that CgSnf1p can associate with the components of S. cerevisiae regulatory mechanisms. The observation that the snf1 disruption mutants lost their ability to utilize trehalose further supports this assumption.
Direct selection of S. cerevisiae mutants complemented for both the uracil auxotrophy and sucrose utilization on YNBS agar was significantly less efficient. A similar phenomenon was observed when the mutant was complemented with the C. albicans SNF1 gene homolog (23a). This phenomenon may be the result of the double selection. It may reflect, however, the requirement for basal levels of Snf1p to derepress the transcription of genes necessary for sucrose utilization.
In S. cerevisiae, Snf1p was suggested to play a role in other cellular processes in addition to the catabolic repression pathway (29) . Such a hypothesis may be supported by the presence of a histidine residue stretch at the amino-terminal end of the protein in which mutations had no effect on glucose catabolic repression (6) . A similar structure was observed in C. glabrata and C. albicans (13-mer in ScSNF1 and 12-mer in CaSNF1 and CgSNF1), indicating that this unique nickel binding site is well conserved and suggesting a yet unknown functional significance.
The carbon utilization spectrum of C. glabrata is extremely narrow and most of the glucose-repressible carbon sources are not utilized. It is interesting that the complex mechanism for the catabolic repression was preserved in such an organism. Trehalose, a nonreducing disaccharide of glucose, was first thought to serve as a storage molecule. Recent studies, however, have shown that this disaccharide plays a role in protection mechanisms against various environmental stresses such as heat shock, frost, and high osmolarity in yeasts, filamentous fungi, and bacteria (26, 30) . It may well be that the involvement of trehalose in the various cellular processes requires strict regulation of its catabolism and accounts for the maintenance of this regulatory pathway.
Since the carbon utilization pattern of C. glabrata is much simpler than that of S. cerevisiae or C. albicans, C. glabrata snf1 mutants may prove to be a useful model for the study of carbon catabolic regulation.
